ASCO: Apalutamide + ADT Beneficial in High-Risk Localized Prostate Cancer

FRIDAY, June 5, 2026-- Perioperative treatment with apalutamide and androgen deprivation therapy (ADT) is beneficial for patients with high-risk localized or locally advanced prostate cancer, according to a study published online June 2 in the New...